| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 547 | 450 | +21.5% |
| EBITDA | 32.6 | −26.7 | — |
| EBITDA margin | 6.0% | −5.9% | +11.9 pts |
| Profit before tax | −39.1 | −64.4 | — |
| Net profit | −43.7 | −60.0 | — |
| EPS | −₹3.62 | −₹5.86 | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 1,445 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 64.0 | 64.0 | 183 | 440 | 350 | ||
| 2,093 | 2,093 | 1,707 | 1,163 | 441 | ||
| 3,474 | — | — | — | — | ||
| 1,832 | 1,736 | 2,050 | 2,083 | 2,132 | ||
| — | −15.3% | −1.6% | −2.3% | — | ||
| 20.0 | −35.2 | 48.8 | 51.0 | 186 | ||
| 1.1% | −2.0% | 2.4% | 2.5% | 8.7% | ||
| −69.7 | −124 | −12.3 | −12.2 | 131 | ||
| −152 | −168 | −46.1 | −38.8 | 89.8 | ||
| −8.3% | −9.7% | −2.3% | −1.9% | 4.2% | ||
| −₹12.57 | −₹13.92 | −₹3.82 | −₹3.22 | ₹7.45 | ||
| — | −264.2% | −18.8% | −143.2% | — | ||
| — | −131 | −66.0 | 237 | 54.1 | ||
| — | −599 | −613 | −811 | −363 | ||
| −730 | −730 | −679 | −574 | −309 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 1,445.0 | |
| - Cash, Equiv & ST Investments | 349.6 | 439.7 | 182.9 | 64.0 | 64.0 | |
| + Total Debt | 441.1 | 1,163.3 | 1,706.6 | 2,093.0 | 2,093.0 | |
| Enterprise Value | — | — | — | — | 3,474.0 | |
| Revenue | 2,132.2 | 2,083.1 | 2,049.5 | 1,735.5 | 1,832.1 | |
| Growth %, YoY | — | -2.3 | -1.6 | -15.3 | — | |
| EBITDA | 186.2 | 51.0 | 48.8 | -35.2 | 20.0 | |
| Margin % | 8.73 | 2.45 | 2.38 | -2.03 | 1.09 | |
| EBIT | 130.5 | -12.2 | -12.3 | -123.5 | -69.7 | |
| Net Income | 89.8 | -38.8 | -46.1 | -167.9 | -151.6 | |
| Margin % | 4.21 | -1.86 | -2.25 | -9.67 | -8.28 | |
| EPS, Adj (current shares) | 7.45 | -3.22 | -3.82 | -13.92 | -12.57 | |
| Growth %, YoY | — | -143.2 | -18.8 | -264.2 | — | |
| Cash from Operations | 54.1 | 237.1 | -66.0 | -130.7 | — | |
| Capital Expenditures | -362.8 | -810.7 | -612.9 | -599.3 | — | |
| Free Cash Flow | -308.6 | -573.7 | -678.9 | -730.0 | -730.0 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Thirumalai Chemicals (NSE: TIRUMALCHM) had a market capitalisation of ₹1,379 crore at the 30 October 2026 close (₹114.33 a share) and a price-to-book ratio of 0.88. In FY26 its consolidated net loss was ₹168 crore on revenue of ₹1,736 crore; in Q1 FY27 (April–June 2026) it was a loss of ₹43.7 crore. Its debt-to-equity ratio was 1.34 on 31 March 2026. Promoters held 37.13% of the shares on 30 September 2026.
Thirumalai Chemicals' PE ratio is not meaningful at the 30 October 2026 close: its consolidated net profit over the last four quarters (Q2 FY26 to Q1 FY27) was a loss of ₹152 crore, and a price-to-earnings ratio needs positive earnings. Its market capitalisation was ₹1,379 crore at ₹114.33 a share.
Thirumalai Chemicals' price-to-book (PB) ratio is 0.88 at the 30 October 2026 close: a market capitalisation of ₹1,379 crore divided by shareholders' equity (book value) of ₹1,564 crore on 31 March 2026. That is a book value of ₹129.65 per share against a share price of ₹114.33.
In FY26, Thirumalai Chemicals' return on equity (ROE) was −12.4% and its return on capital employed (ROCE) was −3.9%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was −4.0% and ROCE −0.5%.
Thirumalai Chemicals' market capitalisation was ₹1,379 crore at the 30 October 2026 close: 12.06 crore shares at ₹114.33 each.
No. Thirumalai Chemicals had borrowings of ₹2,093 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 1.34. Its cash and current investments were ₹262 crore, so its net debt was ₹1,831 crore.
Thirumalai Chemicals' basic earnings per share (EPS) were −₹14.91 in FY26, against −₹4.50 in FY25.
Thirumalai Chemicals' debt-to-equity ratio was 1.34 on 31 March 2026: borrowings of ₹2,093 crore against total equity of ₹1,564 crore. A year earlier, on 31 March 2025, it was 1.48.
Thirumalai Chemicals' book value per share was ₹129.65 on 31 March 2026: shareholders' equity of ₹1,564 crore divided by the 12.06 crore shares in issue. The share price at the 30 October 2026 close was ₹114.33.
Promoters held 37.13% of Thirumalai Chemicals on 30 September 2026, unchanged from the previous quarter and up 1.00 percentage points from 36.13% a year earlier, according to the shareholding pattern filed with NSE.
Thirumalai Chemicals' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,564 crore on 31 March 2026, up 35.3% from ₹1,156 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,379 crore at the 30 October 2026 close.
In FY26, Thirumalai Chemicals generated ₹131 crore of cash from operations and spent ₹599 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹730 crore. In FY25 it was −₹679 crore.
Thirumalai Chemicals' latest results are for Q1 FY27 (April–June 2026), filed on 4 August 2026: consolidated net loss ₹43.7 crore, narrower than the loss of ₹60 crore in Q1 FY26; revenue from operations ₹547 crore, up 21.5% year on year.
On 30 September 2026, Thirumalai Chemicals' shares were held by promoters 37.13%, foreign portfolio investors (FII/FPI) 1.39%, domestic institutions (DII) 6.72% (including mutual funds at 6.11%) and retail and other non-institutional investors 54.75%. Over the year, FII holding was down 0.76 percentage points from 2.15% and DII holding was down 2.60 percentage points from 9.32%.
On FY26 consolidated figures, against Paushak and Deepak Nitrite: Thirumalai Chemicals' operating margin of −7.1% is the lowest of the three (Paushak 18.0%, Deepak Nitrite 9.6%; peer average 13.8%); its return on equity of −12.4% is the lowest of the three (Paushak 8.0%, Deepak Nitrite 9.8%; peer average 8.9%).
In FY26, Thirumalai Chemicals earned net profit of ₹168 crore on revenue of ₹1,736 crore, against ₹39.3 crore on ₹219 crore for Paushak. Thirumalai Chemicals' operating margin was −7.1% (Paushak 18.0%) and its return on equity −12.4% (Paushak 8.0%). At the 30 October 2026 close, Thirumalai Chemicals' market capitalisation was ₹1,379 crore against ₹1,450 crore for Paushak.
In FY26 (April 2025–March 2026), Thirumalai Chemicals' consolidated net loss was ₹168 crore, wider than the loss of ₹46.1 crore in FY25, on revenue from operations of ₹1,736 crore (down 15.3%).
Thirumalai Chemicals has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
From Thirumalai Chemicals' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.